Laura Mele Selected Research

MME

2/2003

Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Mele Research Topics

Disease

3	Atherosclerosis 12/2018 - 01/2015
1	Vascular Ring 11/2023
1	Body Weight (Weight, Body) 01/2019
1	Binge Drinking 12/2018
1	Obesity 01/2017
1	Atherosclerotic Plaque (Atheroma) 01/2015
1	Malignant Mesothelioma 02/2003
1	Neoplasms (Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

2	CholesterolIBA 12/2018 - 01/2016
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2023
1	Adenosine Triphosphate (ATP)IBA 11/2023
1	Messenger RNA (mRNA)IBA 01/2019
1	Transcription Factor Brn-3BIBA 01/2019
1	Angiotensin IIIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	HDL CholesterolIBA 12/2018
1	Radioisotopes (Radionuclides)IBA 12/2018
1	ApolipoproteinsIBA 12/2018
1	TeaIBA 01/2017
1	ellagitanninIBA 01/2016
1	AntioxidantsIBA 01/2015
1	PhenolsIBA 01/2015
1	Coffee FDA Link 01/2015
1	Interleukin-4 (Interleukin 4)IBA 02/2003
1	CytokinesIBA 02/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2003
1	AntigensIBA 02/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2003
1	Interferon-gamma (Interferon, gamma)IBA 02/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2003
1	MMEIBA 02/2003
1	Tuberculin (PPD)IBA 02/2003